Literature DB >> 18551613

Norwalk virus: how infectious is it?

Peter F M Teunis1, Christine L Moe, Pengbo Liu, Sara E Miller, Lisa Lindesmith, Ralph S Baric, Jacques Le Pendu, Rebecca L Calderon.   

Abstract

Noroviruses are major agents of viral gastroenteritis worldwide. The infectivity of Norwalk virus, the prototype norovirus, has been studied in susceptible human volunteers. A new variant of the hit theory model of microbial infection was developed to estimate the variation in Norwalk virus infectivity, as well as the degree of virus aggregation, consistent with independent (electron microscopic) observations. Explicit modeling of viral aggregation allows us to express virus infectivity per single infectious unit (particle). Comparison of a primary and a secondary inoculum showed that passage through a human host does not change Norwalk virus infectivity. We estimate the average probability of infection for a single Norwalk virus particle to be close to 0.5, exceeding that reported for any other virus studied to date. Infected subjects had a dose-dependent probability of becoming ill, ranging from 0.1 (at a dose of 10(3) NV genomes) to 0.7 (at 10(8) virus genomes). A norovirus dose response model is important for understanding its transmission and essential for development of a quantitative risk model. Norwalk virus is a valuable model system to study virulence because genetic factors are known for both complete and partial protection; the latter can be quantitatively described as heterogeneity in dose response models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551613     DOI: 10.1002/jmv.21237

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  301 in total

1.  Application of a receptor-binding capture quantitative reverse transcription-PCR assay to concentrate human norovirus from sewage and to study the distribution and stability of the virus.

Authors:  Peng Tian; David Yang; Liangwen Pan; Robert Mandrell
Journal:  Appl Environ Microbiol       Date:  2011-11-18       Impact factor: 4.792

2.  Two-year systematic study to assess norovirus contamination in oysters from commercial harvesting areas in the United Kingdom.

Authors:  James A Lowther; Nicole E Gustar; Andrew L Powell; Rachel E Hartnell; David N Lees
Journal:  Appl Environ Microbiol       Date:  2012-06-08       Impact factor: 4.792

3.  Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus.

Authors:  Verónica Costantini; LaDonna Grenz; Angela Fritzinger; David Lewis; Christianne Biggs; Antony Hale; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

4.  Norovirus gastroenteritis successfully treated with nitazoxanide.

Authors:  Danish M Siddiq; Hoonmo L Koo; Javier A Adachi; George M Viola
Journal:  J Infect       Date:  2011-08-09       Impact factor: 6.072

Review 5.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

6.  The state of norovirus vaccines.

Authors:  Kari Debbink; Lisa C Lindesmith; Ralph S Baric
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

7.  Assessment of gastroenteric viruses from wastewater directly discharged into Uruguay River, Uruguay.

Authors:  M Victoria; L F L Tort; M García; A Lizasoain; L Maya; J P G Leite; M P Miagostovich; J Cristina; R Colina
Journal:  Food Environ Virol       Date:  2014-04-29       Impact factor: 2.778

8.  Wipes coated with a singlet-oxygen-producing photosensitizer are effective against human influenza virus but not against norovirus.

Authors:  Katharina Verhaelen; Martijn Bouwknegt; Saskia Rutjes; Ana Maria de Roda Husman; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

Review 9.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

Review 10.  Chronic norovirus infection and common variable immunodeficiency.

Authors:  J Woodward; E Gkrania-Klotsas; D Kumararatne
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.